BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11960332)

  • 1. Unique molecular and cellular features of acute myelogenous leukemia stem cells.
    Jordan CT
    Leukemia; 2002 Apr; 16(4):559-62. PubMed ID: 11960332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia: where does it stem from?
    Grimwade D; Enver T
    Leukemia; 2004 Mar; 18(3):375-84. PubMed ID: 14737069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the studies of acute myelogenous leukemia stem cell].
    Cui JW; Zhang XM; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
    Jordan CT; Guzman ML
    Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential induction of apoptosis for primary human leukemic stem cells.
    Guzman ML; Swiderski CF; Howard DS; Grimes BA; Rossi RM; Szilvassy SJ; Jordan CT
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16220-5. PubMed ID: 12451177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: myeloid-restricted hematopoietic stem cells with self-renewal capacity may be the transformation site in acute myeloid leukemia.
    Satoh C; Ogata K
    Leuk Res; 2006 Apr; 30(4):491-5. PubMed ID: 16183117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of morphocytochemical and immunophenotypic features of acute leukemia stem cells.
    Gluzman DF; Nadgornaya VA; Sklyarenko LM; Zavelevych MP; Koval SV; Poludnenko LY; Ivanovskaya TS
    Exp Oncol; 2008 Jun; 30(2):102-5. PubMed ID: 18566571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Haematologica; 2000 Feb; 85(2):124-32. PubMed ID: 10681718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
    Chopra M; Bohlander SK
    Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
    Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
    Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
    Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Realistic pathologic classification of acute myeloid leukemias.
    Arber DA
    Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotypic analysis in acute leukemia].
    Akashi K; Harada M
    Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
    Mahlknecht U; Schönbein C
    Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and leukaemic stem cells.
    Bonnet D
    Br J Haematol; 2005 Aug; 130(4):469-79. PubMed ID: 16098060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
    Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
    Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.